• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴毒素-β受体是黑色素瘤细胞中NF-κB介导转录的上游激活剂。

The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells.

作者信息

Dhawan Punita, Su Yingjun, Thu Yee Mon, Yu Yingchun, Baugher Paige, Ellis Darrel L, Sobolik-Delmaire Tammy, Kelley Mark, Cheung Timothy C, Ware Carl F, Richmond Ann

机构信息

Department of Veterans Affairs, Nashville, TN 37212, USA.

出版信息

J Biol Chem. 2008 May 30;283(22):15399-408. doi: 10.1074/jbc.M708272200. Epub 2008 Mar 17.

DOI:10.1074/jbc.M708272200
PMID:18347013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2397477/
Abstract

The pleiotropic transcription factor nuclear factor-kappaB (NF-kappaB (p50/p65)) regulates the transcription of genes involved in the modulation of cell proliferation, apoptosis, and oncogenesis. Furthermore, a host of solid and hematopoietic tumor types exhibit constitutive activation of NF-kappaB (Basseres, D. S., and Baldwin, A. S. (2006) 25, 6817-6830). However, the mechanism for this constitutive activation of NF-kappaB has not been elucidated in the tumors. We have previously shown that NF-kappaB-inducing kinase (NIK) protein and its association with Inhibitor of kappaB kinase alphabeta are elevated in melanoma cells compared with their normal counterpart, leading to constitutive activation of NF-kappaB. Moreover, expression of dominant negative NIK blocked this base-line NF-kappaB activity in melanoma cells. Of the three receptors that require NIK for activation of NF-kappaB, only the lymphotoxin-beta receptor (LTbeta-R) is expressed in melanoma. We show in this manuscript that for melanoma there is a strong relationship between expression of the LTbeta-R and constitutive NF-kappaB transcriptional activity. Moreover, we show that activation of the LTbeta-R can drive NF-kappaB activity to regulate gene expression that leads to enhanced cell growth. The inhibition by LTbeta-R shRNA resulted in decreased NF-kappaB promoter activity, decreased growth, and decreased invasiveness as compared with control. These results indicate that the LTbeta-R constitutively induces NF-kappaB activation, and this event may be associated with autonomous growth of melanoma cells.

摘要

多效转录因子核因子-κB(NF-κB(p50/p65))调节参与细胞增殖、凋亡和肿瘤发生调控的基因转录。此外,许多实体瘤和血液肿瘤类型均表现出NF-κB的组成性激活(Basseres, D. S., and Baldwin, A. S. (2006) 25, 6817 - 6830)。然而,肿瘤中NF-κB这种组成性激活的机制尚未阐明。我们之前已经表明,与正常对应物相比,黑色素瘤细胞中NF-κB诱导激酶(NIK)蛋白及其与κB激酶αβ抑制剂的结合升高,导致NF-κB的组成性激活。此外,显性负性NIK的表达阻断了黑色素瘤细胞中的这种基线NF-κB活性。在激活NF-κB需要NIK的三种受体中,只有淋巴毒素-β受体(LTβ-R)在黑色素瘤中表达。我们在本论文中表明,对于黑色素瘤,LTβ-R的表达与组成性NF-κB转录活性之间存在密切关系。此外,我们表明LTβ-R的激活可驱动NF-κB活性以调节导致细胞生长增强的基因表达。与对照相比,LTβ-R shRNA的抑制导致NF-κB启动子活性降低、生长减少和侵袭性降低。这些结果表明,LTβ-R组成性诱导NF-κB激活,并且这一事件可能与黑色素瘤细胞的自主生长有关。

相似文献

1
The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells.淋巴毒素-β受体是黑色素瘤细胞中NF-κB介导转录的上游激活剂。
J Biol Chem. 2008 May 30;283(22):15399-408. doi: 10.1074/jbc.M708272200. Epub 2008 Mar 17.
2
Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.淋巴毒素-β 受体-NIK 信号诱导 RELB/NF-κB2 的替代激活,以促进头颈部癌症中的转移基因表达和细胞迁移。
Mol Carcinog. 2019 Mar;58(3):411-425. doi: 10.1002/mc.22938. Epub 2018 Nov 28.
3
Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma.淋巴毒素β激活的 LTBR/NIK/RELB 轴驱动胆管癌的增殖。
Liver Int. 2024 Nov;44(11):2950-2963. doi: 10.1111/liv.16069. Epub 2024 Aug 20.
4
Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.非规范 NF-κB 信号中的负反馈通过 IKKα 介导的磷酸化调节 NIK 的稳定性。
Sci Signal. 2010 May 25;3(123):ra41. doi: 10.1126/scisignal.2000778.
5
NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway.核因子-κB 诱导激酶(NIK)通过 β-连环蛋白通路调节存活相关因子的表达来调节黑色素瘤的发生。
Oncogene. 2012 May 17;31(20):2580-92. doi: 10.1038/onc.2011.427. Epub 2011 Oct 3.
6
Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells.组成型IκB激酶活性与人黑素瘤细胞中的核因子-κB激活相关。
Cancer Res. 2001 Jun 15;61(12):4901-9.
7
Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.核因子诱导激酶:骨桥蛋白诱导的丝裂原活化蛋白激酶/核因子κB抑制蛋白激酶依赖性核因子κB介导的前基质金属蛋白酶-9激活中的关键调节因子。
Glycoconj J. 2006 May;23(3-4):221-32. doi: 10.1007/s10719-006-7927-1.
8
Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression.黑色素瘤中Akt/蛋白激酶B的组成性激活导致核因子-κB上调和肿瘤进展。
Cancer Res. 2002 Dec 15;62(24):7335-42.
9
Epigenetic alteration of the NF-κB-inducing kinase (NIK) gene is involved in enhanced NIK expression in basal-like breast cancer.NF-κB 诱导激酶(NIK)基因的表观遗传改变参与基底样乳腺癌中 NIK 表达的增强。
Cancer Sci. 2010 Nov;101(11):2391-7. doi: 10.1111/j.1349-7006.2010.01685.x. Epub 2010 Aug 24.
10
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.杂乱突变激活多发性骨髓瘤中的非经典核因子κB通路。
Cancer Cell. 2007 Aug;12(2):131-44. doi: 10.1016/j.ccr.2007.07.003.

引用本文的文献

1
Tumor treating fields induced senescence on glioblastoma.肿瘤治疗电场可诱导胶质母细胞瘤发生衰老。
Am J Cancer Res. 2023 Nov 15;13(11):5626-5640. eCollection 2023.
2
Global Trends in Research of NF-B in Melanoma from 2000 to 2021: A Study of Bibliometric Analysis.2000年至2021年黑色素瘤中NF-κB研究的全球趋势:文献计量分析研究
J Oncol. 2022 Sep 10;2022:3684228. doi: 10.1155/2022/3684228. eCollection 2022.
3
IL22BP Mediates the Antitumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and Humans.IL22BP 介导淋巴毒素对小鼠和人类结直肠肿瘤的抗肿瘤作用。
Gastroenterology. 2020 Oct;159(4):1417-1430.e3. doi: 10.1053/j.gastro.2020.06.033. Epub 2020 Jun 22.
4
Expression of Immune System-Related Membrane Receptors CD40, RANK, BAFFR and LTβR is Associated with Clinical Outcome of Operated Non-Small-Cell Lung Cancer Patients.免疫系统相关膜受体CD40、RANK、BAFFR和LTβR的表达与接受手术治疗的非小细胞肺癌患者的临床结局相关。
J Clin Med. 2019 May 24;8(5):741. doi: 10.3390/jcm8050741.
5
SM22α suppresses cytokine-induced inflammation and the transcription of NF-κB inducing kinase (Nik) by modulating SRF transcriptional activity in vascular smooth muscle cells.SM22α通过调节血管平滑肌细胞中血清反应因子(SRF)的转录活性,抑制细胞因子诱导的炎症反应以及NF-κB诱导激酶(Nik)的转录。
PLoS One. 2017 Dec 28;12(12):e0190191. doi: 10.1371/journal.pone.0190191. eCollection 2017.
6
Lymphotoxin β receptor activation promotes bladder cancer in a nuclear factor-κB-dependent manner.淋巴毒素β受体激活以一种核因子κB依赖的方式促进膀胱癌。
Mol Med Rep. 2015 Feb;11(2):783-90. doi: 10.3892/mmr.2014.2826. Epub 2014 Oct 30.
7
Negative feedback regulation of NF-κB-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosis.NF-κB 诱导激酶的负反馈调节是依赖于蛋白酶体的,但不需要细胞凋亡抑制剂。
Biochem Biophys Res Commun. 2014 Jul 18;450(1):341-6. doi: 10.1016/j.bbrc.2014.05.122. Epub 2014 Jun 2.
8
Role of Tertiary Lymphoid Structures (TLS) in Anti-Tumor Immunity: Potential Tumor-Induced Cytokines/Chemokines that Regulate TLS Formation in Epithelial-Derived Cancers.三级淋巴结构(TLS)在抗肿瘤免疫中的作用:潜在的肿瘤诱导细胞因子/趋化因子调节上皮源性癌症中 TLS 的形成。
Cancers (Basel). 2014 Apr 23;6(2):969-97. doi: 10.3390/cancers6020969.
9
Role of the Lymphotoxin/LIGHT System in the Development and Maintenance of Reticular Networks and Vasculature in Lymphoid Tissues.淋巴毒素/LIGHT系统在淋巴组织中网织网络和脉管系统发育及维持中的作用
Front Immunol. 2014 Feb 11;5:47. doi: 10.3389/fimmu.2014.00047. eCollection 2014.
10
Association between genetic variations in tumor necrosis factor receptor genes and survival of patients with T-cell lymphoma.肿瘤坏死因子受体基因的遗传变异与T细胞淋巴瘤患者生存率之间的关联。
Chin J Cancer. 2012 Jul;31(7):335-41. doi: 10.5732/cjc.011.10448. Epub 2012 May 24.

本文引用的文献

1
Multiple myeloma: lusting for NF-kappaB.多发性骨髓瘤:对核因子κB的渴望
Cancer Cell. 2007 Aug;12(2):95-7. doi: 10.1016/j.ccr.2007.07.010.
2
Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth.κB激酶的全身靶向抑制剂可抑制黑色素瘤肿瘤生长。
Cancer Res. 2007 Apr 1;67(7):3127-34. doi: 10.1158/0008-5472.CAN-06-3547.
3
Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.核因子-κB与κB激酶抑制因子通路在肿瘤发生起始及进展过程中的作用
Oncogene. 2006 Oct 30;25(51):6817-30. doi: 10.1038/sj.onc.1209942.
4
Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy.以激动剂抗体靶向淋巴毒素-β受体作为一种潜在的癌症治疗方法。
Cancer Res. 2006 Oct 1;66(19):9617-24. doi: 10.1158/0008-5472.CAN-06-0217.
5
The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development.从生物化学到生物学的替代性核因子κB信号通路:未来药物开发的陷阱与前景
Biochem Pharmacol. 2006 Oct 30;72(9):1161-79. doi: 10.1016/j.bcp.2006.08.007. Epub 2006 Sep 12.
6
BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways.BMS-345541靶向κB激酶抑制剂并诱导黑色素瘤细胞凋亡:核因子κB和线粒体途径的参与
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):950-60. doi: 10.1158/1078-0432.CCR-05-1220.
7
Constitutive expression and costimulatory function of LIGHT/TNFSF14 on human melanoma cells and melanoma-derived microvesicles.LIGHT/TNFSF14在人黑色素瘤细胞及黑色素瘤衍生微泡上的组成性表达及共刺激功能
Cancer Res. 2005 Apr 15;65(8):3428-36. doi: 10.1158/0008-5472.CAN-04-3239.
8
Deregulated Akt3 activity promotes development of malignant melanoma.Akt3活性失调促进恶性黑色素瘤的发展。
Cancer Res. 2004 Oct 1;64(19):7002-10. doi: 10.1158/0008-5472.CAN-04-1399.
9
Cytosolic, nuclear and nucleolar localization signals determine subcellular distribution and activity of the NF-kappaB inducing kinase NIK.胞质、核和核仁定位信号决定了核因子κB诱导激酶NIK的亚细胞分布和活性。
J Cell Sci. 2004 Jul 15;117(Pt 16):3615-24. doi: 10.1242/jcs.01224.
10
Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.核因子诱导激酶在骨桥蛋白诱导的丝裂原活化蛋白激酶/核因子κB抑制蛋白激酶依赖性核因子κB介导的前基质金属蛋白酶-9激活中起关键作用。
J Biol Chem. 2004 Sep 10;279(37):38921-35. doi: 10.1074/jbc.M404674200. Epub 2004 Jul 7.